RF
RPRX icon

Rossby Financial’s Royalty Pharma RPRX Stock Holding History

Rossby Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4K Buy
275
+130
+90% +$6.77K ﹤0.01% 1039
2026
Q1 		$7.03K Buy
145
+5
+4% +$219 ﹤0.01% 1379
2025
Q4 		$5.41K Buy
140
+38
+37% +$1.45K ﹤0.01% 1091
2025
Q3 		$3.71K Buy
+102
New +$3.69K ﹤0.01% 1034

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rossby Financial's RPRX Position: Q2 2026 in Review

Rossby Financial increased its Royalty Pharma (RPRX) stake by 90% in Q2 2026, buying an estimated $6.77K and bringing the position to 275 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Rossby Financial first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Rossby Financial held 275 shares of Royalty Pharma worth $15.4K as of Q2 2026.
  • Rossby Financial bought 130 Royalty Pharma shares in Q2 2026, an estimated $6.77K.
  • Royalty Pharma made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1039 holding.
  • Rossby Financial first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.